Healthtech Startups
16,794 companies tagged Healthtech, with their investors and founders.
DynamiCare offers a digital recovery platform that uses behavioral science and technology to help individuals reduce or eliminate their use of alcohol, drugs, and tobacco. The product focuses on addiction recovery and substance use treatment.
3 investors
Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding. It is a medical device for people with hearing loss.
3 investors
Ease Health builds an AI-native electronic health record system designed for behavioral health practices that integrates CRM, EHR, and revenue cycle management into a single platform. The system targets behavioral health clinics and practices seeking to reduce administrative burden and improve operational efficiency.
3 investors
EasyHealth partners with health plans and provider groups to deliver proactive in-home, in-clinic, and virtual preventive care to Medicare, Medicaid, and Health Exchange members. Using a hybrid model where medical assistants run in-home diagnostics and nurse practitioners complete assessments via telehealth, it closes care gaps and improves quality measures such as HEDIS and STARS.
3 investors
EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software. It serves the cardiology and electrophysiology field, targeting patient treatment backed by clinical evidence.
3 investors
EBR Systems develops the WiSE cardiac pacing system, a leadless and physiologic medical device for treating heart failure patients. The company serves physicians and hospitals providing cardiac rhythm management and conduction system pacing solutions.
3 investors
EDGE10 Group provides electronic health record systems and performance analytics software for professional sports teams and leagues. The company serves athletes, medical staff, and sports organizations requiring medical compliance and performance management solutions.
3 investors
EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform. It focuses on treatments for genetic diseases and cancer.
3 investors
EIO Diagnostics develops a thermal sensor-based mastitis monitoring system for dairy farmers that detects udder health issues to reduce infections. The UdderHealth Mastitis system integrates into various dairy parlor styles to serve farms of all sizes.
3 investors
EirSystems builds medication management infrastructure for healthcare providers and EHR platforms, focusing on electronic medication administration records and opioid prescription monitoring across long-term care, behavioral health, and post-acute settings. The company was founded by physicians and engineers to improve clinical workflows and reduce medication administration errors.
3 investors
Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
3 investors
Elemental Machines provides an IoT platform combining hardware, software, and data science to monitor lab and manufacturing equipment, environments, and workflows in real time. It serves R&D, manufacturing, academia, and government science operations with continuous monitoring, contextual alerts, and GxP/GMP/GLP compliance support.
3 investors
Elucid develops artificial intelligence technology that analyzes CT images to identify hidden features of cardiovascular risk and guide personalized treatment of coronary artery disease. The platform enables physicians to create detailed disease maps and deliver personalized care based on individual patient anatomy.
3 investors
Elysium develops healthcare products focused on aging research and healthy aging rather than disease treatment. The company translates aging research into accessible solutions for individuals seeking to improve their long-term health outcomes.
3 investors
Elythea develops machine learning models that analyze patient data during early pregnancy visits to identify women at risk of severe obstetric complications such as preeclampsia, postpartum hemorrhage, and preterm labor, enabling physicians to intervene months before potential crises occur.
3 investors
3 investors
Empirical is a heart health company that uses comprehensive lab testing, AI-powered risk modeling, and evidence-based interventions to prevent cardiovascular disease. It serves consumers seeking proactive heart disease prevention through personalized, affordable care enabled by value-based care models and machine learning.
3 investors
Empo Health develops in-home health monitoring devices for diabetic patients and healthcare providers to improve care outcomes. The company serves diabetes management in the digital health space.
3 investors
Empower Sleep offers virtual sleep care, connecting patients with sleep doctors for online provider visits, at-home sleep testing, and personalized treatment plans based on continuous sleep tracking data. It serves consumers seeking sleep health support and accepts qualifying insurance plans.
3 investors
Endomag makes the Magseed marker, a magnetic seed used to localize breast cancer lesions before and during surgery as an alternative to guidewire localization. It serves surgeons and radiologists treating breast cancer patients in the medical device field.
3 investors
Endomedix is developing PLEXimine, a technology platform based on polysaccharide chemistry that lets surgeons form structured medical devices in situ during procedures. The company focuses on biosurgery and related medical applications.
3 investors
EndoShunt develops a catheter-based device to control hemorrhage in traumatic vascular injuries, featuring a length-adjustable occlusion zone, temporary deployment, and an atraumatic tip. The company has functional prototypes validated in benchtop and in vivo studies and is pursuing FDA 510(k) clearance.
3 investors
Endpoint Health develops immunology-focused therapeutics paired with diagnostic tests designed to match individual patients with treatments suited to their biology for critical and chronic illnesses.
3 investors
EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration. The company serves the pharmaceutical and biotech industry and originated from research at the University of Bath.
3 investors